Balance and Mild Traumatic Brain Injury: The Effect of a Weighted Compression Vest

N/A

Waitlist Available

Led By Shannon McGuire, BScPT

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Diagnosed concussion. Symptoms persistent for more than 3 months. Self-reported balance deficits. Participants have been referred by a physician to the Outpatient ABI team at Parkwood. Participants have been screened by the ABI team and are currently awaiting treatment. No other diagnosed orthopedic injuries or significant health conditions. Able to follow instructions

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this will take less than 10 minutes to administer. it will be administered twice: once on intervention day 1, and once on intervention day 2 (1 week apart). the outcome measures will be administered in the same sequence each intervention day.

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if wearing a weighted vest helps people with balance problems after a mild brain injury. Patients will do balance and walking tests with and without the vest. The study aims to see if the vest improves balance, reduces fatigue, and lowers anxiety. Weighted vest exercises may play a role in the rehabilitation of balance in those with paraplegia.

Eligible Conditions

Concussion

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this will take less than 10 minutes to administer. it will be administered twice: once on intervention day 1, and once on intervention day 2 (1 week apart). the outcome measures will be administered in the same sequence each intervention day.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this will take less than 10 minutes to administer. it will be administered twice: once on intervention day 1, and once on intervention day 2 (1 week apart). the outcome measures will be administered in the same sequence each intervention day.

This trial's timeline: 3 weeks for screening, Varies for treatment, and this will take less than 10 minutes to administer. it will be administered twice: once on intervention day 1, and once on intervention day 2 (1 week apart). the outcome measures will be administered in the same sequence each intervention day. for reporting.